Press releases

All press releases Regulatory

Regulatory press release 2020-09-25

Xspray announces positive preliminary results from the study for its lead product candidate HyNap-Dasa

Regulatory press release 2020-09-21

Michael Wolff Jensen will not stand for re-election as Chairman of Xspray Pharma AB

Regulatory press release 2020-08-31

Number of shares and votes in Xspray

Press release 2020-08-31

Xspray announces positive stability data on HyNap-Dasa tablets

Regulatory press release 2020-08-21

Warrant holders exercise all warrants within the framework of incentive program

Regulatory press release 2020-08-18

Xspray strengthens the value of the product portfolio with patent protection for tablet of dasatinib propylene glycol solvate

Regulatory press release 2020-08-12

Xspray announces preliminary results from the first study for its lead product candidate HyNap-Dasa

Press release 2020-08-03

Xspray enters manufacturing collaboration in Malta

Regulatory press release 2020-07-31

Xspray Pharma publishes Interim Report Q2, January – June 2020

Press release 2020-07-03

First study group has been dosed in Xspray Pharma’s ongoing pivotal registration studies with HyNap-Dasa

IR contact

Kerstin Hasselgren, IRO / Senior Adviser

+46 (0)70 311 16 83

info@xspray.com

Subscribe